REFERENCES
- McCarty C A, Bansal A K, Livingston P M, et al. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 1998; 105: 1114–1119
- Schein O D, Munoz B, Tielsch J M, et al. Prevalence of dry eye among the elderly. Am J Ophthamol 1997; 124: 723–728
- Fox RI. Pathogenesis of Sjogren's syndrome. Rheum Dis Clin North Am 1992; 18: 517–538
- Gordon T P, Bolstad A I, Rischmueller M, et al. Autoantibodies in primary Sjogren's syndrome: New insights into mechanisms of autoantibody diversification and disease pathogenesis. Autoimmunity 2001; 34: 123–132
- Zoukhri D, Hodges R R, Byon D, et al. Role of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia. Invest Ophthalmol Vis Sci 2002; 43: 1429–1436
- Plugfelder S C. Perspective, anti-inflammatory therapy for dry eye. Am J Ophthalmol 2004; 137: 337–342
- Sullivan D A, Belanguer A, Cermark J M, et al. Are women with Sjogren's syndrome androgen deficient?. J Rheumatol 2003; 30: 2413–2419
- Nagler R M, Pollack S. Sjogren's syndrome induced by estrogen therapy. Semin Arthritis Rheum 2000; 30: 209–214
- Schaumberg D A, Sullivan D A, Buring J E, et al. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003; 136: 318–326
- Hakala M, Niemela R K. Does autonomic nervous impairment have a role in pathophysiology of Sjogren's syndrome?. Lancet 2000; 355: 1032–1033
- Fox R I. Use of cevimeline, a muscarinic M1 and M3 agonist, in the treatment of Sjogren's syndrome. Adv Exp Med Biol 2002; 506: 1107–1116
- Toker E, Yavuz S, Direskeneli H. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjogren's syndrome. Br J Ophthalmol 2004; 88: 384–387
- Manthorpe R, Frost-Larsen K, Isager H, et al. Sjogren's syndrome: A review with emphasis on immunological features. Allergy 1981; 36: 139–153
- Masaoka T, Shibata H, Kakishita A, et al. Phase II study of FK 506 for allogenic bone marrow transplantation. Transplant Proc 1991; 23: 3228–3231
- Ogawa Y, Okamoto S, Kuwana M, et al. Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK 506 and corticosteroids. Cornea 2001; 20: 430–434
- Aoki S, Mizote H, Minamoto A, et al. Systemic FK506 improved tear secretion in dry eye associated with chronic graft-versus-host disease. Br J Ophthalmol 2005; 89: 243–244
- Merayo-Lloves J, Baltatzis S, Foster C S. Epstein-Barr virus dacryoadenitis resulting in keratoconjunctivitis sicca in a child. Am J Ophthalmol 2001; 132: 922–923
- Fujita M, Igarashi T, Kurai T, et al. Correlation between dry eye and rheumatoid arthritis activity. Am J Ophthalmol 2005; 140: 808–813
- Zoukhri D. Effect of inflammation on lacrimal gland function. Exp Eye Research 2006; 82: 885–898